Rankings / Comparisons
Ashwagandha (Withania somnifera) vs Rhodiola rosea
Two adaptogens with overlapping marketing claims and very different evidence bases.
Reviewed by Read Off Label · How we grade
Bottom line
On the composite score, Rhodiola rosea (B+, 7.1/10) edges out Ashwagandha (Withania somnifera) (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.
B- 6.3/10
aka KSM-66, Sensoril
- Evidence
- Moderate (stress/anxiety; small testosterone effect in men per Lopresti 2019; modest muscle/strength gains) (6/10)
- Benefit
- Moderate (5/10)
- Risk
- Low-Med (hepatotoxicity — emerging case reports since 2020; thyroid hormone elevation — caution in hyperthyroidism or on levothyroxine; sedating; theoretical concerns with autoimmune conditions) (7/10 safety)
- Legality
- OTC
- Dose
- 300-600 mg/day standardized extract (KSM-66 or Sensoril most studied)
- Class
- Herbal
- Last reviewed
- Jun 8, 2026
Read Off Label grades Ashwagandha (Withania somnifera) as B- (6.3/10) based on moderate evidence, moderate benefit magnitude, and a low-med-risk safety profile.
Most-popular adaptogen in the West, with better clinical trial base than most (Chandrasekhar 2012, Lopresti 2019, 2021).
Typical use: 300-600 mg/day standardized extract (KSM-66 or Sensoril most studied) — OTC.
What it is
Most-popular adaptogen in the West, with better clinical trial base than most (Chandrasekhar 2012, Lopresti 2019, 2021). Iceland and Denmark added warnings 2023 after multiple case reports of DILI (drug-induced liver injury). Take time-separated from thyroid hormone (can affect absorption). Cycle if using chronically. Emerging 2025-2026 case reports describe HPA-axis suppression and withdrawal-type symptoms with chronic use — too sparse to establish incidence but reinforcing the case for cycling. A 2026 meta-analysis (20 RCTs, n=1,249) reported significant cognitive gains - memory SMD 0.52, attention/processing speed SMD 0.29 - plus muscle-strength, testosterone, and body-composition improvements (GRADE-assessed; Front Pharmacol 2026).
Mechanism
Ayurvedic 'Indian ginseng'; withanolides (withaferin A, withanolide D); HPA axis modulation — reduces cortisol response to stress; GABAergic; thyroid-stimulating effects
Full Ashwagandha (Withania somnifera) review →
- Evidence
- Moderate (fatigue, burnout, mild depression, exercise recovery) (6/10)
- Benefit
- Med (5/10)
- Risk
- Low (generally well-tolerated) (9/10 safety)
- Legality
- OTC
- Dose
- 200-600 mg/day standardized extract (3% rosavin, 1% salidroside)
- Class
- Herbal
- Last reviewed
- Jun 8, 2026
Read Off Label grades Rhodiola rosea as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.
Best-studied adaptogen outside of ashwagandha.
Typical use: 200-600 mg/day standardized extract (3% rosavin, 1% salidroside) — OTC.
What it is
Best-studied adaptogen outside of ashwagandha. Effects generally described as subtle — reduced fatigue and stress tolerance rather than acute stimulation. Most notable in fatigue/burnout states.
Mechanism
Arctic adaptogen; rosavins and salidrosides; modulates HPA axis and monoamine metabolism; reduces cortisol response to stress; mitochondrial support
Full Rhodiola rosea review →
Common questions
- Which is better, Ashwagandha (Withania somnifera) or Rhodiola rosea?
- On the composite score, Rhodiola rosea (B+, 7.1/10) edges out Ashwagandha (Withania somnifera) (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.
- What's the difference between Ashwagandha (Withania somnifera) and Rhodiola rosea?
- Two adaptogens with overlapping marketing claims and very different evidence bases.
- Can you take Ashwagandha (Withania somnifera) and Rhodiola rosea together?
- Read Off Label doesn't make stack recommendations — see the disclaimer. Both compounds have individual mechanism, dose, and risk profiles documented on their respective pages; combining them is a clinical question that depends on the goal, indication, and other context.
This is an independent synthesis of published research by a non-clinician.
Comparison-page verdicts use the composite Read Off Label score as a
tiebreaker, but the right pick for any given person depends on indication,
context, and clinician input. See the full
disclaimer and methodology.